SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001520138-18-000323
Filing Date
2018-11-14
Accepted
2018-11-14 12:15:24
Documents
41
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q FOR PERIOD ENDED SEPTEMBER 30, 2018 bivi-20180930_10q.htm 10-Q 265582
2 EXHIBIT 31.1 bivi-20180930_10qex31z1.htm EX-31.1 12315
3 EXHIBIT 31.2 bivi-20180930_10qex31z2.htm EX-31.2 12341
4 EXHIBIT 32.1 bivi-20180930_10qex32z1.htm EX-32.1 4996
5 EXHIBIT 32.2 bivi-20180930_10qex32z2.htm EX-32.2 4998
  Complete submission text file 0001520138-18-000323.txt   1633596

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE bivi-20180930.xml EX-101.INS 214372
7 XBRL SCHEMA FILE bivi-20180930.xsd EX-101.SCH 23258
8 XBRL CALCULATION FILE bivi-20180930_cal.xml EX-101.CAL 26116
9 XBRL DEFINITION FILE bivi-20180930_def.xml EX-101.DEF 62791
10 XBRL LABEL FILE bivi-20180930_lab.xml EX-101.LAB 178600
11 XBRL PRESENTATION FILE bivi-20180930_pre.xml EX-101.PRE 129813
Mailing Address 11601 WILSHIRE BLVD. SUITE 1100 LOS ANGELES CA 90025
Business Address 11601 WILSHIRE BLVD. SUITE 1100 LOS ANGELES CA 90025 312-283-5793
BIOVIE INC. (Filer) CIK: 0001580149 (see all company filings)

IRS No.: 462510769 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-55292 | Film No.: 181181887
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1